RSV 2010: Recent advances in research on respiratory syncytial virus and other pneumoviruses
Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) are important causes of acute respiratory tract disease in infants, immunocompromised patients and the elderly. The Seventh International RSV symposium was held in Rotterdam, the Netherlands, from December 2-5, 2010. This symposium is the flagship event for leading investigators engaged in RSV and HMPV research around the world. The objective of the symposium was to provide a forum to review recent advances in research on RSV, HMPV and other pneumoviruses. More than 200 young and established investigators attended the meeting. Over a hundred papers were presented in 55 oral presentations and six poster sessions, providing all participants the opportunity to share and to discuss their work. The Chanock lecture, instituted in 2003 to acknowledge important contributors to RSV research, was presented by Peter Collins. As a preface to his lecture, he presented an in memoriam of the late Dr. Robert M. Chanock, who played a key role in the characterization of RSV as a human pathogen. The current report presents highlights of the meeting, covering topics from basic virology, pathogenesis and immunology to clinical studies, therapeutics and vaccine development.
|Keywords||Immunology, Pathogenesis, RSV, HMPV, Replication, Therapy, Vaccination|
|Persistent URL||dx.doi.org/10.1016/j.vaccine.2011.07.114, hdl.handle.net/1765/30722|
van Bleek, G.M., Osterhaus, A.D.M.E., & de Swart, R.L.. (2011). RSV 2010: Recent advances in research on respiratory syncytial virus and other pneumoviruses. Vaccine, 29(43), 7285–7291. doi:10.1016/j.vaccine.2011.07.114